Screener
Ginkgo Bioworks DNA EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Ginkgo Bioworks’s reported figures.
Based on trailing twelve months.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
FAQ
- What is Ginkgo Bioworks's EBITDA margin?
- Ginkgo Bioworks (DNA) reported EBITDA margin of -211.6% in Q2 2026.
- How has Ginkgo Bioworks's EBITDA margin changed year-over-year?
- Ginkgo Bioworks's EBITDA margin decreased by 89.2% year-over-year, from -111.8% to -211.6%.
- What is the long-term trend for Ginkgo Bioworks's EBITDA margin?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's EBITDA margin has grown at a -27.2% compound annual growth rate (CAGR), from -573.4% to -161%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Ginkgo Bioworks's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude